Clinical trials
COVID clinical trials
Below are recruiting covid clinical trials, each written for real people, not researchers. We’re tracking 334 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05233605Recruiting
Study sedative effects on ongoing brain inflammation after severe COVID
This study looks at whether a specific ICU sedative (dexmedetomidine) affects long-term inflammation in the brain after severe COVID with ARDS and deep sedation. It uses PET and MRI scans and special tracers to understand persistent inflammation and why it may last.
ParisAges 18–74 - NCT07530757Recruiting
SuperCAP: An App Program to Help Post-COVID Brain Fog
This study tests a smartphone app designed to help people with long-COVID improve their thinking and daily activities. You'll use the app about 15 minutes a day, 5 days a week, to work on cognitive skills and functioning.
Badalona, BarcelonaAges 18–65 - NCT07504341Recruiting
Managing COVID-19 with vital signs
This trial looks at how patients' basic health signs like blood pressure and breathing rate affect their COVID-19 treatment. Doctors will review hospital records from a specific time period to learn more.
Chiayi CityAges Any age - NCT07464314RecruitingPhase 1
Testing a combined flu and COVID-19 mRNA vaccine in older adults
This trial is testing whether a new mRNA vaccine that targets both seasonal flu and COVID-19 is safe and creates a strong immune response. It may offer an easier way to protect against two illnesses with one shot.
Anniston, AlabamaAges 65–85 - NCT05126589Recruiting
COVID-19 respiratory sample testing using virus genetic clues
This study looks at respiratory samples from adults after COVID-19 to better understand what viruses may be present and how they change over time. If you live in Hong Kong and can consent, you may be able to help researchers learn from your samples and symptoms.
Hong Kong, Hong KongAges 18 years+ - NCT06792214RecruitingPhase 4
Testing if antivirals prevent long-term heart problems after COVID-19
This study tests whether two antiviral medications, Paxlovid and Veklury (remdesivir), can reduce the risk of long-term heart and blood vessel problems after a COVID-19 infection. It is for adults recently hospitalized with COVID-19 who are not currently on oxygen therapy.
Kingston, OntarioAges 18 years+ - NCT05898529Recruiting
Testing COVID status in children having surgery
This study looks at how COVID-19 infection is handled in children (ages 2–17) who are scheduled for surgery. The goal is to compare testing/safety approaches and see how they may protect pediatric surgical patients.
Surrey, British ColumbiaAges 2–17 - NCT07417176Recruiting
Persistent COVID-19 registry study in Navarre
This study is a registry for people in Navarre, Spain, who have long-lasting COVID-19 symptoms (more than 3 months). By joining, you help doctors learn more about persistent COVID and how to care for it.
Pamplona, NavarreAges Any age - NCT07406217RecruitingPhase 2
Optimizing antivirals for immunocompromised COVID-19 patients
This trial tests whether an optimized antiviral treatment can help people with weakened immune systems who have COVID-19. It aims to find the best way to treat them to prevent severe illness.
Basel, BaselAges 16 years+ - NCT07400848Recruiting
Symptoms and recovery after COVID-19 vaccine
This study looks at people who developed new, long-lasting symptoms after a COVID-19 vaccine. It aims to understand their symptoms, do lab tests, and see how they recover over time.
BernAges 18 years+ - NCT06829940Recruiting
Baduanjin exercise for long COVID fatigue
This trial tests whether Baduanjin, a gentle mind-body exercise, can help people under 50 with long-standing chronic fatigue that's worse after COVID-19. It aims to see if this safe, low-impact practice improves energy and daily life without needing extra treatments.
CairoAges 18–50 - NCT04790240RecruitingPhase 1/Phase 2
Herbal treatment aimed to reduce COVID-19 inflammation
This early-stage trial studies whether certain medical herbs can lower inflammation in people with recent COVID-19 and help the immune system better fight the virus. You may be able to join whether or not you take standard COVID medicines, but you would need to complete the herb plan and provide specific lab and scan results.
Rockville, MarylandAges Any age - NCT05822193Recruiting
Study of long COVID in Brazil
This study looks at how often “post-COVID-19 condition” (long COVID) happens, what factors are linked to it, and how much it affects people’s daily lives. It may help researchers better understand long COVID and who is most impacted.
Cachoeirinha, Rio Grande do SulAges 18 years+ - NCT07374562Recruiting
Nerve block for Long COVID symptoms
This study tests a nerve block injection (called a stellate ganglion block) to see if it can help relieve ongoing symptoms of Long COVID, especially breathing problems. It is for people who have had COVID-19 symptoms for at least 3 months.
Trois-Rivières, QuebecAges 18 years+ - NCT07356570Recruiting
Post-COVID care tracking study for long-term symptoms
This study follows people with lasting or complex COVID-19 symptoms who are already in a specialized care program. It aims to better understand and improve recovery after COVID.
Pierre-BéniteAges 18 years+ - NCT07343856Enrolling by invitation
Long COVID diagnostic test study
This study is testing a new, non-invasive way to diagnose Long COVID using a simple bioelectrical assessment. It might help if you've had COVID-19 and have been dealing with ongoing symptoms for 12 weeks or longer.
TashkentAges 18–75 - NCT06191302Recruiting
Long COVID study in Denmark
This study follows people who were hospitalized for COVID-19 to learn more about long-term health effects (post-COVID conditions). It uses blood samples already collected during their hospital stay.
HvidovreAges 18 years+ - NCT07312409Recruiting
Taurine for long COVID vascular health
This study tests whether taking taurine supplements can improve blood vessel function and help with dizziness or fainting caused by long COVID.
Toronto, OntarioAges 18–65 - NCT07298005RecruitingPhase 2
A study of Sonlicromanol for post-COVID patients
This trial tests a medicine called Sonlicromanol to see if it helps people with lingering symptoms after a mild case of COVID-19. It is for people who have post-exertional malaise (feeling very tired or worse after activity) and a moderate level of disability.
Amsterdam, North HollandAges 18–65 - NCT07302295Recruiting
How COVID-19 affected suicidal behavior in kids
This study looks at how the COVID-19 pandemic affected suicidal behavior in children and teens. Researchers want to compare episodes that happened during the pandemic (2020-2022) with those just before (2018-2019) to understand if there was a change.
BronAges 8–18 - NCT06876948Recruiting
Long COVID brain effects in children
This study looks at brain and nerve problems in children and teens who had COVID-19. It uses brain scans and other tests to understand long-lasting symptoms like headaches, tiredness, memory issues, or dizziness.
Pisa, PIAges 6–16 - NCT06879925Recruiting
Qi-Gong therapy for long COVID recovery
This study tests whether gentle Qi-Gong exercises can improve physical health and quality of life for people with lingering COVID-19 symptoms (long COVID). It may help if you're over 20 and struggling with post-COVID issues.
New Taipei CityAges 20–100 - NCT06881160Recruiting
Micro-RNA and COVID-19 study
This trial studies tiny molecules in your body called micro-RNAs (miRNAs) that may help understand how COVID-19 affects people. Participants donate blood and swab samples to see if these molecules can predict how sick someone might get.
Roma, RMAges 18 years+ - NCT07285707Recruiting
Acupuncture and herbs for long COVID
This small study tests whether acupuncture and Chinese herbal medicine can help relieve common long COVID symptoms like fatigue, cough, brain fog, and pain. It might be a good fit if you are struggling with ongoing symptoms after COVID and are looking for a treatment approach that isn't just more medication.
Whittier, CaliforniaAges 18 years+
Hear when a new COVID trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for covid?
- Yes. Clin2 currently lists 334 recruiting covid studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a covid trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a covid trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.